LBA EIS Roundtable Syndicate Fund 2016

"2016 was a great year for Advizzo with strong traction from the utilities market and great interest from investors. Such pre-series A is a great achievement for Advizzo with a fruitful collaboration with London Business Angels and the LCIF which did a follow-up investment alongside experienced private investors who know the utilities industry trends very well. We will continue to expand in 2017 locally and internationally with additional software modules."

"We have made significant progress over the past year and, thanks to the support of Angel networks, are well-positioned to grow as the use of novel materials in medical devices increases."

"Bringing these technologies together will allow us to provide rapid access to accurate blood testing outside hospital which could transform the delivery of healthcare."

"Eagle Genomics which is now at scale up stage is commercialising an effective bioinformatics software solution that has the potential to improve the way in which new medicines and therapies are developed. This round of growth capital funding from existing and new angel investors leaves the company well positioned to accelerate its growth in this fast growing market."